Caduet

DRUG3 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Hyo-Soo Kim

Conditions

Angina PectorisDyslipidemiaDyslipidemiasHypercholesterolemiaHypertension

Phase 4

Caduet in an Untreated Subject Population

CompletedNCT00332761

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Dyslipidemia, Hypertension

Start: 2006-06-30End: 2007-09-30Target: 220Updated: 2021-01-27

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

CompletedNCT01190007

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Angina Pectoris, Hypercholesterolemia, Hypertension

Start: 2010-08-31End: 2012-02-29Updated: 2021-01-28

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

CompletedNCT03860220

Hyo-Soo KimDyslipidemias, Hypertension

Start: 2019-04-25End: 2023-09-07Updated: 2026-04-27

Related Papers

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial

Current Therapeutic Research2024-01-013 citations